Thomas Christopher A, Anderson Ryan J, Condon David F, de Jesus Perez Vinicio A
Division of Pulmonary, Allergy and Critical Care Medicine, Stanford University, Stanford, CA, USA.
Vera Moulton Wall Center for Pulmonary Vascular Research, Stanford University, Stanford, CA, USA.
Pulm Ther. 2020 Jun;6(1):9-22. doi: 10.1007/s41030-019-00105-5. Epub 2019 Nov 29.
The past 20 years have seen major advances in the diagnosis and management of pulmonary hypertension, a disease associated with significant morbidity and mortality. The 6th World Symposium in Pulmonary Hypertension (WSPH) took place in February 2018 and attempted to consolidate the current knowledge in the field into practical recommendations to help prioritize an action plan to improve patient outcomes and identify future research directions. In this review, we will summarize the highlights of the 6th WSPH proceedings, including revisions to the hemodynamic definitions and classification of the various types of pulmonary hypertension, genetic advances, approaches to risk stratification, and updated treatment algorithms.
在过去20年里，肺动脉高压的诊断和管理取得了重大进展，这是一种与高发病率和死亡率相关的疾病。第六届世界肺动脉高压研讨会（WSPH）于2018年2月举行，试图将该领域的现有知识整合为实用建议，以帮助确定改善患者预后的行动计划优先级，并确定未来的研究方向。在本综述中，我们将总结第六届WSPH会议的要点，包括对各种类型肺动脉高压的血流动力学定义和分类的修订、遗传学进展、风险分层方法以及更新的治疗算法。
